510(k) Report

510(k) · Cleared

Cleared

Careside Uric Acid

K981604510(k) TraditionalCleared Jun 25, 199858-day reviewClass I21 CFR 862.1775

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Careside, Inc. · KNK Acid, Uric, Uricase (Colorimetric)

Cleared on Jun 25, 1998 as substantially equivalent to K912844 (Eastman Kodak Company, 1991) after a 58-day review. Its family tree reaches back 1 generation to 1991.

Decided
Jun 25, 1998
Review
58 days
Class
Class I
Product code
KNK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K912844 (1991). No later device cites it as a predicate yet.

K912844 · Kodak Ektachem Dtii System · Eastman Kodak Company · 1991199019921994199619982000
K912844 · Kodak Ektachem Dtii System · Eastman Kodak Company · 19910
  1. Root · 1 generation backK912844 Kodak Ektachem Dtii SystemEastman Kodak Company · 1991
  2. This deviceK981604 Careside Uric AcidCareside, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K912844Kodak Ektachem Dtii SystemEastman Kodak Company1991—
0 (this device)K981604Careside Uric AcidCareside, Inc.1998—
FIG. 1 — Lineage of K981604, 1991–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KNK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K912844Kodak Ektachem Dtii System
Summary page 1
…the Vitros DT 60 IL Johnson and Johnson’s (formerly Eastman Kodak, Inc.) Vitros URIC Slides for Johnson and Johnson’s Vitros DT 60 (formerly Eastman Kodak’s DT 60 II). K912844/A 75JHB Name of Predicate Device: Predicate Device 510K number: Product Code: CARESIDE, Inc. CARESIDE™ Uric Aci…
Eastman Kodak Company1991—

Also cleared against K912844: 28 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 28 other devices also cite its predicate K912844.

How does its category compare?

All KNK devices

KNK Acid, Uric, Uricase (Colorimetric): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KNK

1in 2011

2007: 12011: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KNK

Too few KNK 510(k)s in any year since 2007 to give a median.

Recalls per year · KNK

1in 2018

2009: 22013: 12014: 12016: 22018: 12026 (partial year): 1
2007high 2 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KNK

2in 2025

2007: 12011: 72019: 12020: 22023: 42024: 22025: 2
2007high 7 (2011) · low 0 (2008)2025

MAUDE reports naming product code KNK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
20080—00
20090—20
20100—00
20111—07
20120—00
20130—10
20140—10
20150—00
20160—20
20170—00
20180—10
20190—01
20200—02
20210—00
20220—00
20230—04
20240—02
20250—02
20260—1—

What is it indicated for?

For in vitro diagnostic use with the CARESIDE™ Analyzer to quantitatively measure uric acid from whole blood, plasma or serum specimens to aid in the diagnosis and treatment of patients with numerous renal and metabolic disorders including renal failure, gout, leukemia, psoriasis, starvation or wasting conditions, and of patients receiving cytotoxic drugs. It is intended for professional laboratory use: not for point of care or physician office laboratory use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981604: Careside Uric Acid.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K981604

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026